NEW YORK, NY, March 13, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this
morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Methanex
Corporation (NASDAQ:MEOH), YPF Sociedad Anonima (NYSE:YPF), Adaptimmune Therapeutics PLC (NASDAQ:ADAP), Horizon Pharma PLC
(NASDAQ:HZNP), Changyou.com Limited (NASDAQ:CYOU), and China Yuchai International Limited (NYSE:CYD), including updated fundamental
summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.
Complimentary Access: Research Reports
Full copies of recently published reports are available to readers at the links below.
MEOH DOWNLOAD: http://Fundamental-Markets.com/register/?so=MEOH
YPF DOWNLOAD: http://Fundamental-Markets.com/register/?so=YPF
ADAP DOWNLOAD: http://Fundamental-Markets.com/register/?so=ADAP
HZNP DOWNLOAD: http://Fundamental-Markets.com/register/?so=HZNP
CYOU DOWNLOAD: http://Fundamental-Markets.com/register/?so=CYOU
CYD DOWNLOAD: http://Fundamental-Markets.com/register/?so=CYD
(You may have to copy and paste the link into your browser and hit the [ENTER] key)
The new research reports from Fundamental Markets, available for free download at the links above, examine
Methanex Corporation (NASDAQ:MEOH), YPF Sociedad Anonima (NYSE:YPF), Adaptimmune Therapeutics PLC (NASDAQ:ADAP), Horizon Pharma PLC
(NASDAQ:HZNP), Changyou.com Limited (NASDAQ:CYOU), and China Yuchai International Limited (NYSE:CYD) on a fundamental level and
outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management
discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's
readers below.
-----------------------------------------
Important Notice: the following excerpts are not designed to be standalone
summaries and as such, important information may be missing from these samples. Please download the entire research report, free of
charge, to ensure you are reading all relevant material information. All information in this release was accessed March 9th, 2018.
Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.
-----------------------------------------
METHANEX CORPORATION (MEOH) REPORT OVERVIEW
Methanex's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Methanex reported revenue of $861.43MM vs
$585.59MM (up 47.11%) and basic earnings per share $0.83 vs $0.27 (up 207.41%). For the twelve months ended December 31st, 2017 vs
December 31st, 2016, Methanex reported revenue of $3,060.64MM vs $1,998.43MM (up 53.15%) and basic earnings per share $3.64 vs
-$0.14. Methanex is expected to report earnings on April 25th, 2018. The report will be for the fiscal period ending March 31st,
2018. The reported EPS for the same quarter last year was $1.56. The estimated EPS forecast for the next fiscal year is $5.14 and
is expected to report on January 30th, 2019.
To read the full Methanex Corporation (MEOH) report, download it here: http://Fundamental-Markets.com/register/?so=MEOH
-----------------------------------------
YPF SOCIEDAD ANONIMA (YPF) REPORT OVERVIEW
YPF Sociedad Anonima's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, YPF Sociedad Anonima reported revenue
of $3,829.97MM vs $3,741.88MM (up 2.35%) and basic earnings per share $0.01 vs -$5.17. For the twelve months ended December 31st,
2016 vs December 31st, 2015, YPF Sociedad Anonima reported revenue of $14,223.77MM vs $16,987.60MM (down 16.27%) and basic earnings
per share -$4.88 vs $1.27. YPF Sociedad Anonima is expected to report earnings on April 6th, 2018. The report will be for the
fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was $0.28. The estimated EPS forecast for
the next fiscal year is $1.33 and is expected to report on April 6th, 2018.
To read the full YPF Sociedad Anonima (YPF) report, download it here: http://Fundamental-Markets.com/register/?so=YPF
-----------------------------------------
ADAPTIMMUNE THERAPEUTICS PLC (ADAP) REPORT OVERVIEW
Adaptimmune Therapeutics' Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, Adaptimmune Therapeutics reported
revenue of $27.19MM vs $2.42MM (up 1,025.21%) and basic earnings per share $0.00 vs -$0.24. For the twelve months ended December
31st, 2016 vs June 30th, 2015, Adaptimmune Therapeutics reported revenue of $14.20MM vs $10.75MM (up 32.12%) and basic earnings per
share -$1.01 vs -$0.38. Adaptimmune Therapeutics is expected to report earnings on March 15th, 2018. The report will be for the
fiscal period ending December 31st, 2017. The reported EPS for the same quarter last year was -$0.22. The estimated EPS forecast
for the next fiscal year is -$0.83 and is expected to report on March 15th, 2018.
To read the full Adaptimmune Therapeutics PLC (ADAP) report, download it here: http://Fundamental-Markets.com/register/?so=ADAP
-----------------------------------------
HORIZON PHARMA PLC (HZNP) REPORT OVERVIEW
Horizon Pharma's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Horizon Pharma reported revenue of
$274.22MM vs $310.35MM (down 11.64%) and basic earnings per share -$0.28 vs -$0.81. For the twelve months ended December 31st, 2017
vs December 31st, 2016, Horizon Pharma reported revenue of $1,056.23MM vs $981.12MM (up 7.66%) and basic earnings per share -$2.52
vs -$1.04. Horizon Pharma is expected to report earnings on May 14th, 2018. The report will be for the fiscal period ending March
31st, 2018. The reported EPS for the same quarter last year was $0.21. The estimated EPS forecast for the next fiscal year is $1.77
and is expected to report on February 27th, 2019.
To read the full Horizon Pharma PLC (HZNP) report, download it here: http://Fundamental-Markets.com/register/?so=HZNP
-----------------------------------------
CHANGYOU.COM LIMITED (CYOU) REPORT OVERVIEW
Changyou's Recent Financial Performance
For the three months ended December 31st, 2017 vs December 31st, 2016, Changyou reported revenue of $144.46MM vs
$130.52MM (up 10.68%) and basic earnings per share $0.64 vs $0.79 (down 18.99%). For the twelve months ended December 31st, 2017 vs
December 31st, 2016, Changyou reported revenue of $580.26MM vs $525.39MM (up 10.44%) and basic earnings per share $2.06 vs $2.78
(down 25.90%). Changyou is expected to report earnings on April 23rd, 2018. The report will be for the fiscal period ending March
31st, 2018. The reported EPS for the same quarter last year was $0.56.
To read the full Changyou.com Limited (CYOU) report, download it here: http://Fundamental-Markets.com/register/?so=CYOU
-----------------------------------------
CHINA YUCHAI INTERNATIONAL LIMITED (CYD) REPORT OVERVIEW
China Yuchai International's Recent Financial Performance
For the three months ended September 30th, 2017 vs September 30th, 2016, China Yuchai International reported
revenue of $570.86MM vs $434.81MM (up 31.29%) and basic earnings per share $0.61 vs $0.28 (up 117.86%). For the twelve months ended
December 31st, 2016 vs December 31st, 2015, China Yuchai International reported revenue of $1,987.61MM vs $2,098.25MM (down 5.27%)
and basic earnings per share $1.87 vs $1.35 (up 38.52%). China Yuchai International is expected to report earnings on May 8th,
2018. The report will be for the fiscal period ending March 31st, 2018.
To read the full China Yuchai International Limited (CYD) report, download it here: http://Fundamental-Markets.com/register/?so=CYD
-----------------------------------------
ABOUT FUNDAMENTAL MARKETS
Fundamental Markets serves thousands of members and have provided research through some of the world's leading
brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals
worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA®
BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst®
(CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.
REGISTERED MEMBER STATUS
Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers
("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes
qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers.
Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit
firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries
regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail
at compliance@Fundamental-Markets.com.
LEGAL NOTICES
Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental
Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result
from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the
material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the
publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm,
investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full
disclaimer, disclosure, and terms of service please visit our website.
Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com
© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network
manager at partnership@Fundamental-Markets.com.
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority,
Inc.
